Literature DB >> 16920971

Characterization of the Histoplasma capsulatum-induced granuloma.

Erika Heninger1, Laura H Hogan, Jozsef Karman, Sinarack Macvilay, Bjork Hill, Jon P Woods, Matyas Sandor.   

Abstract

Rising rates of Histoplasma capsulatum infection are an emerging problem among the rapidly growing population of immune-compromised individuals. Although there is a growing understanding of systemic immunity against Histoplasma, little is known about the local granulomatous response, which is an important component in the control of infection. The focus of this article is the characterization of Histoplasma-induced granulomas. Five days after i.p. infection, infected macrophage appear in the liver and lung; however, no granulomas are apparent. Two days later, well-formed sarcoid granulomas are abundant in the lung and liver of infected mice, which contain all visible Histoplasma. Granulomas are dominated by macrophage and lymphocytes. Most of the Histoplasma and most of the apoptotic cells are found in the center of the lesions. We isolated liver granulomas at multiple time points after infection and analyzed the cellular composition, TCR gene usage, and cytokine production of granuloma-infiltrating cells. The lesions contain both CD4+ and CD8+ T cell subsets, and T cells are the primary source of IFN-gamma and IL-17. The main source of local TNF-alpha is macrophage. Chemokines are produced by both infiltrating macrophage and lymphocytes. Dendritic cells are present in granulomas; however, T cell expansion seems to occur systemically because TCR usage is very heterogeneous even at the level of individual lesions. This study is the first direct examination of host cellular responses in the Histoplasma-induced granuloma representing the specific interface between host and pathogen. Our studies will allow further analysis of key elements of host Histoplasma interactions at the site of chronic infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920971      PMCID: PMC2748851          DOI: 10.4049/jimmunol.177.5.3303

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Discordance between T-cell receptor expression and effector function in mice infected with Histoplasma capsulatum.

Authors:  George S Deepe; Reta S Gibbons; Susan R Ward
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28.

Authors:  L H Hogan; W Markofski; A Bock; B Barger; J D Morrissey; M Sandor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Experimental histoplasmosis in mice treated with anti-murine interferon-gamma antibody and in interferon-gamma gene knockout mice.

Authors:  K V Clemons; W C Darbonne; J T Curnutte; R A Sobel; D A Stevens
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

4.  Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity.

Authors:  George S Deepe
Journal:  Clin Infect Dis       Date:  2005-08-01       Impact factor: 9.079

5.  Granulomas Induced by Mycobacterium leprae

Authors: 
Journal:  Methods       Date:  1996-04       Impact factor: 3.608

6.  Hepatic Granulomas in Murine Visceral Leishmaniasis Caused by Leishmania chagasi

Authors: 
Journal:  Methods       Date:  1996-04       Impact factor: 3.608

7.  Functional T cells in primary immune response to histoplasmosis.

Authors:  Jr-Shiuan Lin; Betty A Wu-Hsieh
Journal:  Int Immunol       Date:  2004-09-27       Impact factor: 4.823

8.  Pathologic changes in murine leishmaniasis (Leishmania donovani) with special reference to the dynamics of granuloma formation in the liver.

Authors:  Y Gutierrez; J A Maksem; N E Reiner
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

9.  Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis.

Authors:  C H Ladel; C Blum; A Dreher; K Reifenberg; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

10.  Immunocytochemical analysis of cellular responses to BCG.

Authors:  P H Nibbering; G A van der Heide; R van Furth
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

View more
  27 in total

1.  CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

2.  Virally activated CD8 T cells home to Mycobacterium bovis BCG-induced granulomas but enhance antimycobacterial protection only in immunodeficient mice.

Authors:  Laura H Hogan; Dominic O Co; Jozsef Karman; Erika Heninger; M Suresh; Matyas Sandor
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

Review 3.  Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.

Authors:  Jon P Woods
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

4.  IL-13-regulated Macrophage Polarization during Granuloma Formation in an In Vitro Human Sarcoidosis Model.

Authors:  Landon W Locke; Elliott D Crouser; Peter White; Mark W Julian; Evelyn Guirado Caceres; Audrey C Papp; Van T Le; Wolfgang Sadee; Larry S Schlesinger
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 5.  Impact of HIF-1α and hypoxia on fungal growth characteristics and fungal immunity.

Authors:  Dirk Friedrich; Roger A Fecher; Jan Rupp; George S Deepe
Journal:  Microbes Infect       Date:  2016-10-31       Impact factor: 2.700

Review 6.  The role of dendritic cells in mycobacterium-induced granulomas.

Authors:  Heidi A Schreiber; Matyas Sandor
Journal:  Immunol Lett       Date:  2010-01-04       Impact factor: 3.685

7.  Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.

Authors:  Heidi A Schreiber; Paul D Hulseberg; JangEun Lee; Jozsef Prechl; Peter Barta; Nora Szlavik; Jeffrey S Harding; Zsuzsanna Fabry; Matyas Sandor
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

8.  Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF.

Authors:  Jeremy P McAleer; Robert J Rossi; Anthony T Vella
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

9.  Hepatic IL-17 responses in human and murine primary biliary cirrhosis.

Authors:  Ruth Y Z Lan; Thucydides L Salunga; Koichi Tsuneyama; Zhe-Xiong Lian; Guo-Xiang Yang; Willy Hsu; Yuki Moritoki; Aftab A Ansari; Claudia Kemper; Jeff Price; John P Atkinson; Ross L Coppel; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-12-19       Impact factor: 7.094

Review 10.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.